Within the European Union, the legal framework incentivizes orphan medicinal product development, driven by a commitment to addressing the unmet medical needs of vulnerable patients. Navigating this intricate landscape requires a deep understanding of the legal benefits and obligations, the emerging trends, and the blocking issues.
Join us for an insightful exploration into the EU Orphan Medicinal Products: Legal Framework, Trends and Lesson Learnt presented by our Regulatory Affairs Specialist @Virginia Garcia Munoz
April 30th, 3PM CET
Duration: 1 hour
